on Tuesday reported fourth-quarter earnings and revenue that beat Wall Street's expectations.
Here's how J&J did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:Revenue: $22.48 billion versus $21.67 billion expected. "I'm incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs," J&J CEO Alex Gorsky said in a press release. "We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study soon."
Lol time to face my charts again
Joe3Hendrix
SenatorCollins Sen: Collins you don't want to help or aid the people once again, you refuse to vote for the Pandemic aid for $1,400. dollars to the people of America!!! you just want to help and support the Businesses not the people and so, you get $$ money in your back pocket!
must be read VaccinesWork